RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling.
Saved in:
| Title: | RRM2‐targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling. |
|---|---|
| Authors: | Hou, Weiliang1 (AUTHOR), Hong, Weifeng2 (AUTHOR), Cai, Songhua3 (AUTHOR), Guo, Dandan4 (AUTHOR), Yan, Zhiping5 (AUTHOR), Zhu, Jinyu6 (AUTHOR), Shen, Yang7 (AUTHOR), Wan, Juncheng5 (AUTHOR), Qu, Xudong5 (AUTHOR), Zhang, Wen5 (AUTHOR), Zhao, Runkang4 (AUTHOR), Xie, Zhao4 (AUTHOR), Chen, Zhongji4 (AUTHOR), Jiang, Tong4 (AUTHOR), Lin, Yaling4 (AUTHOR), Jia, Wenlong8 (AUTHOR), Wang, Ling4 (AUTHOR), Huang, Zhao8 (AUTHOR) huangzhao@tjh.tjmu.edu.cn, Li, Xuexin9,10 (AUTHOR) xuexin.li@ki.se, Tang, Bufu5 (AUTHOR) tangbufu@zju.edu.cn |
| Source: | iMeta. Oct2025, Vol. 4 Issue 5, p1-25. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
